0.3474

3.09% 0.0104

After Hours: .35 0.0026 +0.75%

Co Diagnostics Inc (CODX)

Overview News Price History Option Chain Financials Discussions Forecast

Co Diagnostics Inc stock is traded at $0.3474, with a volume of 21,330. It is up +3.09% in the last 24 hours and down -23.14% over the past month. Co-Diagnostics Inc is a molecular diagnostics company. It develops, licenses, and commercializes molecular technologies such as lab systems (MDx device) and manufacture and sell reagents used for tests that are designed using the detection and/or analysis of nucleic acid molecules (DNA or RNA). CDI's low-cost system uses its tests to diagnose tuberculosis, Zika, hepatitis B and C, Malaria, dengue and HIV.The Company's technologies are utilized for tests that are designed using the detection and/or analysis of nucleic acid molecules (DNA or RNA). The Company also uses its proprietary technology to design specific tests for its Co-Dx PCR platform and to locate genetic markers for use in applications other than infectious diseases.

Previous Close:

$0.337

Open:

$0.3501

24h Volume:

21,330

Relative Volume:

0.12

Market Cap:

$11.57M

Revenue:

$7.11M

Net Income/Loss:

$-41.28M

P/E Ratio:

-0.2517

EPS:

-1.38

Net Cash Flow:

$-26.84M

1W Performance:

+3.15%

1M Performance:

-23.14%

6M Performance:

-72.21%

1Y Performance:

-69.53%

1-Day Range:

$0.3242

$0.36

1-Week Range:

$0.301

$0.3945

52-Week Range:

$0.2801

$2.2299

Co Diagnostics Inc Stock (CODX) Company Profile

Name

Co Diagnostics Inc

Sector

Healthcare (1151)

Industry

Medical Devices (153)

Phone

(801) 278-9769

Address

4049 SOUTH HIGHLAND DRIVE, SALT LAKE CITY

Employee

132

Twitter

@Co_Diagnostics

Next Earnings Date

2024-11-07

Latest SEC Filings

CODX's Discussions on Twitter

Compare CODX with other stocks

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
CODX Co Diagnostics Inc	0.3474	11.57M	7.11M	-41.28M	-26.84M	-1.38
ABT Abbott Laboratories	130.98	221.92B	41.95B	13.40B	6.35B	7.65
BSX Boston Scientific Corp	95.12	139.43B	16.75B	1.85B	2.37B	1.25
SYK Stryker Corp	346.50	134.90B	22.60B	2.99B	3.49B	7.76
MDT Medtronic Plc	82.60	108.02B	33.20B	4.26B	5.47B	3.29
EW Edwards Lifesciences Corp	71.53	40.93B	5.72B	4.17B	259.90M	6.97

Co Diagnostics Inc Stock (CODX) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Aug-12-22	Downgrade	Sidoti	Buy → Neutral
Dec-29-21	Initiated	Sidoti	Buy
Mar-29-21	Downgrade	Maxim Group	Buy → Hold
May-20-20	Upgrade	Maxim Group	Hold → Buy
May-18-20	Reiterated	H.C. Wainwright	Buy
Mar-09-20	Reiterated	H.C. Wainwright	Buy
Mar-03-20	Downgrade	Maxim Group	Buy → Hold

View All

Co Diagnostics Inc Stock (CODX) Latest News

Apr 09, 2025

Co-Diagnostics stock hits 52-week low at $0.28 amid market challenges - Investing.com Canada

Apr 09, 2025

Co-Diagnostics stock hits 52-week low at $0.28 amid market challenges By Investing.com - Investing.com South Africa

Apr 09, 2025

Apr 02, 2025

All You Need to Know About CoDiagnostics (CODX) Rating Upgrade to Buy - Yahoo Finance

Apr 02, 2025

Apr 01, 2025

Co-Diagnostics targets 2025 clinical evaluations for TB and HPV tests in India and South Africa - MSN

Apr 01, 2025

Mar 30, 2025

Co-Diagnostics Earnings Call: Progress Amid Challenges - MSN

Mar 30, 2025

HC Wainwright Lowers Co-Diagnostics (NASDAQ:CODX) Price Target to $1.00 - Defense World

Mar 30, 2025

Mar 29, 2025